OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
23
Results
Show all
Save search
Copy query
Show results for
Unknown
(23)
Publication Date
Release Date
2023
(3)
2011
(3)
2024
(2)
2021
(2)
2020
(2)
2018
(2)
2016
(2)
2015
(2)
2025
(1)
2022
(1)
2017
(1)
2014
(1)
2012
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Phase II Study of Lapatinib in Combination With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Clinical Outcomes and Predictive Value of Early [18F]Fluorodeoxyglucose Positron Emission Tomography Imaging (TBCRC 003).
Not available
S-EPMC4534525
|
biostudies-literature
Cite
A Pilot Study of the Combination of Entinostat with Capecitabine in Advanced Breast Cancer.
Not available
S-EPMC10866629
|
biostudies-literature
Cite
Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer.
Not available
S-EPMC8492731
|
biostudies-literature
Cite
The therapeutic relevance of a
BRCA2
mutation in a patient with recurrent thymoma: a case report.
Not available
S-EPMC9792822
|
biostudies-literature
Cite
Tucatinib Combined With Ado-Trastuzumab Emtansine in Advanced ERBB2/HER2-Positive Metastatic Breast Cancer: A Phase 1b Clinical Trial.
Not available
S-EPMC6143009
|
biostudies-literature
Cite
Everolimus Plus Endocrine Therapy for Postmenopausal Women With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: A Clinical Trial.
Not available
S-EPMC5885212
|
biostudies-literature
Cite
A Phase II Randomized Study of Paclitaxel Alone or Combined with Pelareorep with or without Avelumab in Metastatic Hormone Receptor-Positive Breast Cancer: The BRACELET-01/PrE0113 Study.
Not available
S-EPMC12209820
|
biostudies-literature
Cite
An open-label, pilot study of veliparib and lapatinib in patients with metastatic, triple-negative breast cancer.
Not available
S-EPMC7934554
|
biostudies-literature
Cite
Datopotamab-deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial.
Not available
S-EPMC12089997
|
biostudies-literature
Cite
TBCRC 030: a phase II study of preoperative cisplatin versus paclitaxel in triple-negative breast cancer: evaluating the homologous recombination deficiency (HRD) biomarker.
Not available
S-EPMC8437015
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets